Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Flu Vaccine 2006-2007 Strains To Be Determined By Advisory Cmte. Feb. 17

This article was originally published in The Pink Sheet Daily

Executive Summary

The committee will hold annual meeting to decide the influenza strains for the upcoming flu season.

You may also be interested in...

Second Time's The Charm: Novartis' New Bid Lures Chiron

Chiron's vaccines unit will operate as a separate division while its biopharmaceuticals unit will merge with Novartis' pharmaceutical business.

GSK To Gain Fluviral Vaccine Through Acquisition Of ID Biomedical

GlaxoSmithKline plans to acquire ID Biomedical for $1.4 bil., a deal that could provide GSK with a second flu vaccine in the U.S. for the 2006/2007 flu season.

India Highlights "Public Interest" To Reign In Prices For Non-Scheduled Drugs

Dr. Reddy's, GSK, Ranbaxy and UCB among manufacturers that could see prices reduced under government order that reflects issues raised in Gleevec patent dispute.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts